La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease

Identifieur interne : 001F16 ( Main/Exploration ); précédent : 001F15; suivant : 001F17

Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease

Auteurs : R. B. Postuma [Canada] ; J. F. Gagnon [Canada] ; M. Vendette [Canada] ; J. Y. Montplaisir [Canada]

Source :

RBID : ISTEX:017563F841366FD08C2E4CB5920968BEE62021A5

Descripteurs français

English descriptors

Abstract

Idiopathic rapid eye movement sleep behaviour disorder is an important risk factor in the development of Parkinson's disease. Numerous potential predictive markers of Parkinson's disease may present before motor symptoms emerge, but testing of these markers in rapid eye movement sleep behaviour disorder has been performed only in small studies. There has been no comparison of markers between patients with idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease, and between men and women. We evaluated an array of potential Parkinson's disease predictive markers in 159 patients; including 68 with idiopathic rapid eye movement sleep behaviour disorder, 36 controls, 34 Parkinson's patients with rapid eye movement sleep behaviour disorder and 21 Parkinson's patients without rapid eye movement sleep behaviour disorder. Compared with controls, patients with idiopathic rapid eye movement sleep behaviour disorder demonstrated substantial olfactory loss (P < 0.001). Olfaction was more impaired in Parkinson's disease than idiopathic rapid eye movement sleep behaviour disorder and did not differ between Parkinson's patients with, or without, rapid eye movement sleep behaviour disorder. Numerous measures of motor function including the Unified Parkinson Disease Rating Scale alternate tap, Purdue Peg Board and Timed Up and Go were impaired in idiopathic rapid eye movement sleep behaviour disorder compared with controls (P < 0.01). All of these motor measures were worse with Parkinson's disease than with idiopathic rapid eye movement sleep behaviour disorder, regardless of rapid eye movement sleep behaviour disorder status. Autonomic symptoms and systolic blood pressure drop were impaired in patients with idiopathic rapid eye movement sleep behaviour disorder compared with controls (P 0.003). Orthostatic abnormalities in Parkinson's disease were found in the group with rapid eye movement sleep behaviour disorder (P < 0.001). However, Parkinson's patients without rapid eye movement sleep behaviour disorder were not different than controls and had less impairment than those with idiopathic rapid eye movement sleep behaviour disorder (P 0.004) and Parkinson's patients with rapid eye movement sleep behaviour disorder (P < 0.001). Colour vision was impaired in idiopathic rapid eye movement sleep behaviour disorder compared with controls (P < 0.001). However, only Parkinson's patients with rapid eye movement sleep behaviour disorder had abnormalities significantly different than controls (P < 0.001), and there were significant differences between Parkinson's patients with or without rapid eye movement sleep behaviour disorder (P < 0.04). Idiopathic rapid eye movement sleep behaviour disorder patients had slightly increased harm avoidance scores on personality testing (P 0.04). Other than slightly better performances among women in the Purdue Peg Board, there was no difference in any measure between men and women, suggesting similar pathogenic processes underlying rapid eye movement sleep behaviour disorder. Patients with idiopathic rapid eye movement sleep behaviour disorder demonstrate abnormalities in numerous potential markers of neurodegenerative diseasethese markers are heterogeneous, generally correlate with each other and occur equally in men and women. Although these abnormalities are usually intermediate between control values and Parkinson's patients, autonomic dysfunction and colour vision appear to be more linked to rapid eye movement sleep behaviour disorder status than Parkinson's disease, suggesting a unique pathophysiology of these abnormalities.

Url:
DOI: 10.1093/brain/awp244


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease</title>
<author>
<name sortKey="Postuma, R B" sort="Postuma, R B" uniqKey="Postuma R" first="R. B." last="Postuma">R. B. Postuma</name>
</author>
<author>
<name sortKey="Gagnon, J F" sort="Gagnon, J F" uniqKey="Gagnon J" first="J. F." last="Gagnon">J. F. Gagnon</name>
</author>
<author>
<name sortKey="Vendette, M" sort="Vendette, M" uniqKey="Vendette M" first="M." last="Vendette">M. Vendette</name>
</author>
<author>
<name sortKey="Montplaisir, J Y" sort="Montplaisir, J Y" uniqKey="Montplaisir J" first="J. Y." last="Montplaisir">J. Y. Montplaisir</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:017563F841366FD08C2E4CB5920968BEE62021A5</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1093/brain/awp244</idno>
<idno type="url">https://api-v5.istex.fr/document/017563F841366FD08C2E4CB5920968BEE62021A5/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000734</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000734</idno>
<idno type="wicri:Area/Istex/Curation">000734</idno>
<idno type="wicri:Area/Istex/Checkpoint">000692</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000692</idno>
<idno type="wicri:doubleKey">0006-8950:2009:Postuma R:markers:of:neurodegeneration</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:19843648</idno>
<idno type="wicri:Area/PubMed/Corpus">000E06</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E06</idno>
<idno type="wicri:Area/PubMed/Curation">000E06</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000E06</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000E06</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000E06</idno>
<idno type="wicri:Area/Ncbi/Merge">000B64</idno>
<idno type="wicri:Area/Ncbi/Curation">000B64</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B64</idno>
<idno type="wicri:Area/Main/Merge">002069</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:10-0031524</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000475</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000802</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000439</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000439</idno>
<idno type="wicri:doubleKey">0006-8950:2009:Postuma R:markers:of:neurodegeneration</idno>
<idno type="wicri:Area/Main/Merge">002243</idno>
<idno type="wicri:Area/Main/Curation">001F16</idno>
<idno type="wicri:Area/Main/Exploration">001F16</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease</title>
<author>
<name sortKey="Postuma, R B" sort="Postuma, R B" uniqKey="Postuma R" first="R. B." last="Postuma">R. B. Postuma</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1 Department of Neurology, McGill University, Montreal General Hospital, Montral, Quebc</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>2 Centre d'tude du sommeil et des rythmes biologiques, Hpital du Sacr-Coeur, Montral, Qubec</wicri:regionArea>
<wicri:noRegion>Qubec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country>Canada</country>
<wicri:regionArea>Correspondence to: Jacques Montplaisir, MD, PhD, CRCPC, Centre d'tude du sommeil et des rythmes biologiques, Hpital du Sacr-Cur de Montral, 5400 Boul. Gouin Ouest, Montral, Qubec</wicri:regionArea>
<wicri:noRegion>Qubec</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gagnon, J F" sort="Gagnon, J F" uniqKey="Gagnon J" first="J. F." last="Gagnon">J. F. Gagnon</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>2 Centre d'tude du sommeil et des rythmes biologiques, Hpital du Sacr-Coeur, Montral, Qubec</wicri:regionArea>
<wicri:noRegion>Qubec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>3 Department of Psychiatry, Universit de Montral, Qubec</wicri:regionArea>
<wicri:noRegion>Qubec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country>Canada</country>
<wicri:regionArea>Correspondence to: Jacques Montplaisir, MD, PhD, CRCPC, Centre d'tude du sommeil et des rythmes biologiques, Hpital du Sacr-Cur de Montral, 5400 Boul. Gouin Ouest, Montral, Qubec</wicri:regionArea>
<wicri:noRegion>Qubec</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Vendette, M" sort="Vendette, M" uniqKey="Vendette M" first="M." last="Vendette">M. Vendette</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>2 Centre d'tude du sommeil et des rythmes biologiques, Hpital du Sacr-Coeur, Montral, Qubec</wicri:regionArea>
<wicri:noRegion>Qubec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country>Canada</country>
<wicri:regionArea>Correspondence to: Jacques Montplaisir, MD, PhD, CRCPC, Centre d'tude du sommeil et des rythmes biologiques, Hpital du Sacr-Cur de Montral, 5400 Boul. Gouin Ouest, Montral, Qubec</wicri:regionArea>
<wicri:noRegion>Qubec</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Montplaisir, J Y" sort="Montplaisir, J Y" uniqKey="Montplaisir J" first="J. Y." last="Montplaisir">J. Y. Montplaisir</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>2 Centre d'tude du sommeil et des rythmes biologiques, Hpital du Sacr-Coeur, Montral, Qubec</wicri:regionArea>
<wicri:noRegion>Qubec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>3 Department of Psychiatry, Universit de Montral, Qubec</wicri:regionArea>
<wicri:noRegion>Qubec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country>Canada</country>
<wicri:regionArea>Correspondence to: Jacques Montplaisir, MD, PhD, CRCPC, Centre d'tude du sommeil et des rythmes biologiques, Hpital du Sacr-Cur de Montral, 5400 Boul. Gouin Ouest, Montral, Qubec</wicri:regionArea>
<wicri:noRegion>Qubec</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Brain</title>
<idno type="ISSN">0006-8950</idno>
<idno type="eISSN">1460-2156</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date type="published" when="2009-12">2009-12</date>
<biblScope unit="volume">132</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="3298">3298</biblScope>
<biblScope unit="page" to="3307">3307</biblScope>
</imprint>
<idno type="ISSN">0006-8950</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0006-8950</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Autonomic Nervous System Diseases (diagnosis)</term>
<term>Autonomic Nervous System Diseases (etiology)</term>
<term>Autonomic Nervous System Diseases (physiopathology)</term>
<term>Behavioral disorder</term>
<term>Biomarkers</term>
<term>Brain (physiopathology)</term>
<term>Diagnosis, Differential</term>
<term>Female</term>
<term>Humans</term>
<term>Hypotension (diagnosis)</term>
<term>Hypotension (etiology)</term>
<term>Hypotension (physiopathology)</term>
<term>Idiopathic</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nerve Degeneration (diagnosis)</term>
<term>Nerve Degeneration (etiology)</term>
<term>Nerve Degeneration (physiopathology)</term>
<term>Nervous system diseases</term>
<term>Neurologic Examination</term>
<term>Neuropsychological Tests</term>
<term>Olfaction Disorders (diagnosis)</term>
<term>Olfaction Disorders (etiology)</term>
<term>Olfaction Disorders (physiopathology)</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson disease</term>
<term>Prediction</term>
<term>Predictive Value of Tests</term>
<term>REM Sleep Behavior Disorder (complications)</term>
<term>REM Sleep Behavior Disorder (diagnosis)</term>
<term>REM Sleep Behavior Disorder (physiopathology)</term>
<term>Rapid eye movement sleep</term>
<term>Sex Characteristics</term>
<term>Sleep disorder</term>
<term>Vision Disorders (diagnosis)</term>
<term>Vision Disorders (etiology)</term>
<term>Vision Disorders (physiopathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Biomarkers</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Parkinson Disease</term>
<term>REM Sleep Behavior Disorder</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Autonomic Nervous System Diseases</term>
<term>Hypotension</term>
<term>Nerve Degeneration</term>
<term>Olfaction Disorders</term>
<term>Parkinson Disease</term>
<term>REM Sleep Behavior Disorder</term>
<term>Vision Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Autonomic Nervous System Diseases</term>
<term>Hypotension</term>
<term>Nerve Degeneration</term>
<term>Olfaction Disorders</term>
<term>Vision Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Autonomic Nervous System Diseases</term>
<term>Brain</term>
<term>Hypotension</term>
<term>Nerve Degeneration</term>
<term>Olfaction Disorders</term>
<term>Parkinson Disease</term>
<term>REM Sleep Behavior Disorder</term>
<term>Vision Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Diagnosis, Differential</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neurologic Examination</term>
<term>Neuropsychological Tests</term>
<term>Predictive Value of Tests</term>
<term>Sex Characteristics</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Idiopathique</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
<term>Prédiction</term>
<term>Sommeil paradoxal</term>
<term>Trouble du comportement</term>
<term>Trouble du sommeil</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Idiopathic rapid eye movement sleep behaviour disorder is an important risk factor in the development of Parkinson's disease. Numerous potential predictive markers of Parkinson's disease may present before motor symptoms emerge, but testing of these markers in rapid eye movement sleep behaviour disorder has been performed only in small studies. There has been no comparison of markers between patients with idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease, and between men and women. We evaluated an array of potential Parkinson's disease predictive markers in 159 patients; including 68 with idiopathic rapid eye movement sleep behaviour disorder, 36 controls, 34 Parkinson's patients with rapid eye movement sleep behaviour disorder and 21 Parkinson's patients without rapid eye movement sleep behaviour disorder. Compared with controls, patients with idiopathic rapid eye movement sleep behaviour disorder demonstrated substantial olfactory loss (P < 0.001). Olfaction was more impaired in Parkinson's disease than idiopathic rapid eye movement sleep behaviour disorder and did not differ between Parkinson's patients with, or without, rapid eye movement sleep behaviour disorder. Numerous measures of motor function including the Unified Parkinson Disease Rating Scale alternate tap, Purdue Peg Board and Timed Up and Go were impaired in idiopathic rapid eye movement sleep behaviour disorder compared with controls (P < 0.01). All of these motor measures were worse with Parkinson's disease than with idiopathic rapid eye movement sleep behaviour disorder, regardless of rapid eye movement sleep behaviour disorder status. Autonomic symptoms and systolic blood pressure drop were impaired in patients with idiopathic rapid eye movement sleep behaviour disorder compared with controls (P 0.003). Orthostatic abnormalities in Parkinson's disease were found in the group with rapid eye movement sleep behaviour disorder (P < 0.001). However, Parkinson's patients without rapid eye movement sleep behaviour disorder were not different than controls and had less impairment than those with idiopathic rapid eye movement sleep behaviour disorder (P 0.004) and Parkinson's patients with rapid eye movement sleep behaviour disorder (P < 0.001). Colour vision was impaired in idiopathic rapid eye movement sleep behaviour disorder compared with controls (P < 0.001). However, only Parkinson's patients with rapid eye movement sleep behaviour disorder had abnormalities significantly different than controls (P < 0.001), and there were significant differences between Parkinson's patients with or without rapid eye movement sleep behaviour disorder (P < 0.04). Idiopathic rapid eye movement sleep behaviour disorder patients had slightly increased harm avoidance scores on personality testing (P 0.04). Other than slightly better performances among women in the Purdue Peg Board, there was no difference in any measure between men and women, suggesting similar pathogenic processes underlying rapid eye movement sleep behaviour disorder. Patients with idiopathic rapid eye movement sleep behaviour disorder demonstrate abnormalities in numerous potential markers of neurodegenerative diseasethese markers are heterogeneous, generally correlate with each other and occur equally in men and women. Although these abnormalities are usually intermediate between control values and Parkinson's patients, autonomic dysfunction and colour vision appear to be more linked to rapid eye movement sleep behaviour disorder status than Parkinson's disease, suggesting a unique pathophysiology of these abnormalities.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Québec</li>
</region>
<settlement>
<li>Montréal</li>
</settlement>
<orgName>
<li>Université McGill</li>
</orgName>
</list>
<tree>
<country name="Canada">
<region name="Québec">
<name sortKey="Postuma, R B" sort="Postuma, R B" uniqKey="Postuma R" first="R. B." last="Postuma">R. B. Postuma</name>
</region>
<name sortKey="Gagnon, J F" sort="Gagnon, J F" uniqKey="Gagnon J" first="J. F." last="Gagnon">J. F. Gagnon</name>
<name sortKey="Gagnon, J F" sort="Gagnon, J F" uniqKey="Gagnon J" first="J. F." last="Gagnon">J. F. Gagnon</name>
<name sortKey="Gagnon, J F" sort="Gagnon, J F" uniqKey="Gagnon J" first="J. F." last="Gagnon">J. F. Gagnon</name>
<name sortKey="Montplaisir, J Y" sort="Montplaisir, J Y" uniqKey="Montplaisir J" first="J. Y." last="Montplaisir">J. Y. Montplaisir</name>
<name sortKey="Montplaisir, J Y" sort="Montplaisir, J Y" uniqKey="Montplaisir J" first="J. Y." last="Montplaisir">J. Y. Montplaisir</name>
<name sortKey="Montplaisir, J Y" sort="Montplaisir, J Y" uniqKey="Montplaisir J" first="J. Y." last="Montplaisir">J. Y. Montplaisir</name>
<name sortKey="Postuma, R B" sort="Postuma, R B" uniqKey="Postuma R" first="R. B." last="Postuma">R. B. Postuma</name>
<name sortKey="Postuma, R B" sort="Postuma, R B" uniqKey="Postuma R" first="R. B." last="Postuma">R. B. Postuma</name>
<name sortKey="Vendette, M" sort="Vendette, M" uniqKey="Vendette M" first="M." last="Vendette">M. Vendette</name>
<name sortKey="Vendette, M" sort="Vendette, M" uniqKey="Vendette M" first="M." last="Vendette">M. Vendette</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F16 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001F16 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:017563F841366FD08C2E4CB5920968BEE62021A5
   |texte=   Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022